180 research outputs found

    Correlations among selected pork quality traits

    Full text link

    Predicting aged pork quality using a portable Raman device

    Get PDF
    The utility of Raman spectroscopic signatures of fresh pork loin (1 d & 15 d postmortem) in predicting fresh pork tenderness and slice shear force (SSF) was determined. Partial least square models showed that sensory tenderness and SSF are weakly correlated (R2 = 0.2). Raman spectral data were collected in 6 s using a portable Raman spectrometer (RS). A PLS regression model was developed to predict quantitatively the tenderness scores and SSF values from Raman spectral data, with very limited success. It was discovered that the prediction accuracies for day 15 post mortem samples are significantly greater than that for day 1 postmortem samples. Classification models were developed to predict tenderness at two ends of sensory quality as “poor” vs. “good”. The accuracies of classification into different quality categories (1st to 4th percentile) are also greater for the day 15 postmortem samples for sensory tenderness (93.5% vs 76.3%) and SSF (92.8% vs 76.1%). RS has the potential to become a rapid on-line screening tool for the pork producers to quickly select meats with superior quality and/or cull poor quality to meet market demand/expectations

    First πK\pi K atom lifetime and πK\pi K scattering length measurements

    Get PDF
    The results of a search for hydrogen-like atoms consisting of πK±\pi^{\mp}K^{\pm} mesons are presented. Evidence for πK\pi K atom production by 24 GeV/c protons from CERN PS interacting with a nickel target has been seen in terms of characteristic πK\pi K pairs from their breakup in the same target (178±49178 \pm 49) and from Coulomb final state interaction (653±42653 \pm 42). Using these results the analysis yields a first value for the πK\pi K atom lifetime of τ=(2.51.8+3.0)\tau=(2.5_{-1.8}^{+3.0}) fs and a first model-independent measurement of the S-wave isospin-odd πK\pi K scattering length a0=13a1/2a3/2=(0.110.04+0.09)Mπ1\left|a_0^-\right|=\frac{1}{3}\left|a_{1/2}-a_{3/2}\right|= \left(0.11_{-0.04}^{+0.09} \right)M_{\pi}^{-1} (aIa_I for isospin II).Comment: 14 pages, 8 figure

    The Optimal Design of Trade Policy Flexibility in the WTO

    Full text link

    Predictors of retinochoroiditis in children with congenital toxoplasmosis : European, prospective cohort study

    Get PDF
    OBJECTIVE. By school age, 20% of children infected with congenital toxoplasmosis will have > 1 retinochoroidal lesion. We determined which children are most at risk and whether prenatal treatment reduces the risk of retinochoroiditis to help clinicians decide about treatment and follow-up. PATIENTS AND METHODS. We prospectively studied a cohort of children with congenital toxoplasmosis identified by prenatal or neonatal screening in 6 European countries. We determined the effects of prenatal treatment and prognostic markers soon after birth on the age at first detection of retinochoroiditis. RESULTS. Of 281 children with congenital toxoplasmosis, 50 developed ocular disease, and 17 had recurrent retinochoroiditis during a median follow-up of 4.1 years. Prenatal treatment had no significant effect on the age at first or subsequent lesions. Delayed start of postnatal treatment did not increase retinochoroiditis, but the analysis lacked power. Older gestational age at maternal seroconversion was weakly associated with a reduced risk of retinochoroiditis. The presence of nonocular clinical manifestations of congenital toxoplasmosis at birth strongly predicted retinochoroiditis. For 92% (230 of 249) of children with no retinochoroiditis detected before 4 months of age, the probability of retinochoroiditis by 4 years was low, whether clinical manifestations were present or not 8.0%. CONCLUSIONS. Prenatal treatment did not significantly reduce the risk of retinochoroiditis in this European cohort. If children have no retinochoroiditis in early infancy, the low risk of subsequent ocular disease may not justify postnatal treatment and repeated ophthalmic assessments during childhood. Controlled trials are needed to address the lack of evidence for the effectiveness of postnatal treatment
    corecore